A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine

Published:2024-09 Issue:22 Volume:42 Page:126165
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pather Shanti,Charpentier Nicola,van den Ouweland Frank,Rizzi Ruben,Finlayson Andrew,Salisch Nadine,Muik Alexander,Lindemann Claudia,Khanim Ruzwana,Abduljawad Sultan,Smith Emily R.,Gurwith Marc,Chen Robert T.

Publisher

Elsevier BV

Reference216 articles.

1. The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines;Kim;Vaccine,2020

2. The Brighton collaboration viral vector vaccines safety working group (V3SWG);Chen;Vaccine,2015

3. Collaboration B. History. (Accessed 24 Nov 2023, at https://brightoncollaboration.org/history/), 2020.

4. Clinical development and approval of COVID-19 vaccines;Kalinke;Expert Rev Vaccines,2022

5. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA;Martinon;Eur J Immunol,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP